Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Dermatology
•
Atopic Dermatitis
How do you manage atopic dermatitis in patients who have failed dupilumab?
Related Questions
How do you decide between IL-4/IL-13 blockade (dupixent) versus IL-13 blockade only (Adbry) as treatments for Atopic Dermatitis?
What criteria do you utilize in deciding between different jak inhibitors for atopic dermatitis?
Do you prescribe fluocinolone in peanut oil in patients with peanut allergies?
How do you counsel families of pediatric patients on methotrexate about live vaccine schedules?
Do you utilize AIT for atopic dermatitis if there is no AR present?
What is your approach for female patients with severe atopic dermatitis well controlled on Dupixent planning to conceive or already pregnant?
When would you pursue genetic testing for severe recalcitrant atopic dermatitis?
What is your approach for workup and management of prurigo nodularis?
How do you weigh the risks/benefits of cytokine blockade (eg dupilumab) in pregnant patients?
How does omalizumab play a role in the armamentarium of atopic dermatitis?